Mangalam Drugs And Organics Ltd.
Snapshot View

132.75 -2.40 ▼-1.8%

25 November 2022, 04:14:06 PM
Volume: 22,447

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.mangalamdrugs.com
Market Cap 210.52 Cr.
Enterprise Value(EV) 278.46 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 10.07 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 13.20 Trailing Twelve Months Ending 2022-09
Industry PE 35.02 Trailing Twelve Months Ending 2022-09
Book Value / Share 98.46 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.35 Calculated using Price: 133.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.58 Cr. 15,828,248 Shares
FaceValue 10
Company Profile
Mangalam Drugs & Organics Limited (Mangalam) is a part of the MangalamGroup promoted by Dhoot family in 1972 as Advent Pharma PrivateLimited with a view to set up a plant for manufacture of organic andinorganic chemicals. Mangalam Drugs & Organics commmenced its business in 1977.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.78%
1 Week
-1.99%
1 Month
-3.56%
3 Month
-5.82%
6 Month
+21.96%
1 Year
+5.52%
2 Year
-10.67%
5 Year
-19.33%
10 Year
+1417.14%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -12.28 23.36 38.91 32.11 20.99 -8.05 8.27 23.83 13.97
Return on Capital Employed (%) 5.86 15.69 29.14 30.18 25.35 1.76 10.66 28.01 18.34
Return on Assets (%) -2.53 4.16 9.73 12.76 9.56 -3.67 3.73 11.31 6.64

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 23 29 62 86 104 96 104 131 151 156
Non Curr. Liab. 41 41 25 26 23 25 17 24 48 43
Curr. Liab. 61 99 73 78 100 91 109 109 130 175
Minority Int.
Equity & Liab. 125 170 160 190 227 211 231 264 328 375
Non Curr. Assets 54 54 60 94 104 106 111 130 146 155
Curr. Assets 71 116 100 96 123 105 119 134 182 220
Misc. Exp. not W/O
Total Assets 125 170 160 190 227 211 231 264 328 375

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 123 221 295 303 279 228 282 385 451 433
Other Income 0 0 0 0 1 0 1 0 8
Total Income 123 221 295 303 280 228 284 385 451 441
Total Expenditure -113 -200 -258 -257 -233 -218 -259 -327 -402 -397
PBIDT 10 20 38 46 48 10 25 58 49 43
Interest -10 -10 -9 -10 -12 -9 -10 -9 -11 -11
Depreciation -4 -4 -4 -5 -7 -7 -8 -9 -10 -11
Taxation 1 0 -8 -9 -9 -2 2 -12 -8 -5
Exceptional Items
PAT -3 6 16 22 20 -8 8 28 20 16
Adjusted EPS -2 5 11 14 13 -5 5 18 12 10

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -1 7 14 22 43 25 22 31 28 26
Cash Fr. Inv. -2 -2 -4 -11 -39 -16 -9 -7 -31 -27
Cash Fr. Finan. 2 -5 -10 -11 -3 -9 -11 -23 3 3
Net Change -1 0 1 0 0 0 1 0 -1 1
Cash & Cash Eqvt 0 0 1 1 1 0 1 2 1 2

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 50.53 50.53 50.53 50.53 50.53 50.53 50.53 50.42 50.42
Public 49.47 49.47 49.47 49.47 49.47 49.47 49.47 49.58 49.58
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 33.57 33.57 33.57 33.57 11.59 16.88 19.98 16.97 16.22

Announcements View Details >>

Wed, 23 Nov 2022
Related Party Transaction
Mangalam Drugs And Organics Limited has informed the Exchange about related party transaction for the period ended September 2022
Tue, 22 Nov 2022
Related Party Transaction
Mangalam Drugs And Organics Limited has informed the Exchange about related party transaction for the period ended September 2022
Fri, 18 Nov 2022
Newspaper Advertisements
Mangalam Drugs And Organics Limited has informed the Exchange about Newspaper Advertisements for Un-Audited Financial Results of the Company for the period ended September 30, 2022 published in Financial Express (English daily) and Loksatta (Marathi daily).

Technical Scans View Details >>

Fri, 25 Nov 2022
Close Crossing Last Week Low Close Crossing Last Week Low
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
High Increase 6 Months High Increase 6 Months
Closing Near 200 SMA Closing Near 200 SMA

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 247,923.28 1,033.85 -0.1%
Cipla Ltd. 89,193.72 1,105.35 +0.9%
Divi's Laboratories Ltd. 88,708.98 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. 73,559.75 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. 68,713.97 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. 55,107.38 1,628.25 +0.8%
Abbott India Ltd. 43,050.55 20,267.50 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.40 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 34.75 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 29.59 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.60 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 82.06 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.14 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 48.82 20,267.50 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.67 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 4.07 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 7.30 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.53 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.51 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.05 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 15.86 20,267.50 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 0.04 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 0.00 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,267.50 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 798.70 20,267.50 +0.4%

FAQ's On Mangalam Drugs And Organics Ltd.

What is Mangalam Drugs&Org. share price?

Can I buy Mangalam Drugs&Org. shares now?

What is the Market Cap of Mangalam Drugs&Org.?

What are the key metrics to analyse Mangalam Drugs&Org.?

What is the 52 Week High and Low of Mangalam Drugs&Org.?

What is the trend of Mangalam Drugs&Org. share price?